Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...

A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

CardCash.com, Giftify's secondary gift card exchange platform, provides consumers with an innovative approach to reduce rising out-of-pocket expenses for increasingly popular GLP-1 medications. The ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.

GLP-1 receptor agonists, initially developed for type 2 diabetes treatment, work by mimicking a naturally occurring gut ...

At the end of the day, weight loss options, like any other health-related decisions, are very personal and must be made on a ...

Attorney General Kwame Raoul is leading a bipartisan coalition of 37 states and territories urging the Food and Drug ...

Sky-high demand, a high price tag and tight supplies have created opportunities for bad actors to take advantage of consumers ...

Pursuing the world's first-ever orally-dosed liraglutide KELOWNA, BC / ACCESS Newswire / February 20, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global ...

Fitch joined a 37-state coalition requesting that the FDA to take action against bad actors who are endangering consumers with counterfeit weight loss drugs.

While some orthopedic and spine surgeons are divided on how medications used for weight loss, including Ozempic and Wegovy, will shape the field, it is undeniable that the drugs are playing an ...